TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27655061

Group type: EXPERIMENTAL
Intervention: Diagnostic testing before antibiotic prescribing
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Empirical antibiotic use
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Antibiotic use
Number of subjects: 162
Study: 24726098

Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive therapy (<120/80 mm Hg)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Standard antihypertensive therapy (Seventh Joint National Committee compliant)
Number of subjects: 123
Study: 22608823

Group type: EXPERIMENTAL
Intervention: Simulated workplace laboratory for adults with ADHD
Number of subjects: 119

Group type: COMPARATOR
Intervention: Controls without ADHD
Number of subjects: 119
Study: 20922537

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 163

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 163
Study: 18408581

Group type: EXPERIMENTAL
Intervention: At-home care
Number of subjects: 76

Group type: COMPARATOR
Intervention: Hospital care
Number of subjects: 76
Study: 15752954

Group type: EXPERIMENTAL
Intervention: C1 (large artery compliance)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: C2 (small artery compliance)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SV/PP (stroke volume/pulse pressure)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SAC (systemic arterial compliance)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SI (stiffness index)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: AIx (augmentation index)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CPP (central pulse pressure)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Brachial PP (brachial pulse pressure)
Number of subjects: 30
Study: 11751768

Group type: EXPERIMENTAL
Intervention: Erythromycin resistance
Number of subjects: 2586

Group type: EXPERIMENTAL
Intervention: Clindamycin resistance
Number of subjects: 2586

Group type: EXPERIMENTAL
Intervention: Intermediate resistance to penicillin
Number of subjects: 2586

Group type: EXPERIMENTAL
Intervention: Erythromycin-resistant strains
Number of subjects: 2586

Group type: EXPERIMENTAL
Intervention: Correlation with macrolide consumption
Number of subjects: 2586
Study: 10392220

Group type: EXPERIMENTAL
Intervention: Earplugs worn during exposure to noise
Number of subjects: 6

Group type: COMPARATOR
Intervention: No earplugs (noise exposure)
Number of subjects: 6
Study: 8873662

Group type: EXPERIMENTAL
Intervention: Finger artery pressure (with Finapres)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Reconstructed finger pressure after filtering
Number of subjects: 57
Study: 1998226

Group type: EXPERIMENTAL
Intervention: Local anaesthesia
Number of subjects: 91

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 91
Study: 6522132

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 30865149

Group type: EXPERIMENTAL
Intervention: 3 dosing protocols of motor learning-based therapy, identical number of 2-hour sessions over different total calendar weeks
Number of subjects: 75
Study: 30064464

Group type: EXPERIMENTAL
Intervention: Participatory ergonomics intervention conducted over 4 months with three workshops to identify and reduce risk factors for MSP.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participatory ergonomics intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study: 26673246

Group type: EXPERIMENTAL
Intervention: p-synephrine (3 mg·kg(‐1))
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 26529175

Group type: EXPERIMENTAL
Intervention: Heated humidified high flow nasal cannulae (HHHFNC)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (NCPAP)
Number of subjects: 28
Study: 21952795

Group type: EXPERIMENTAL
Intervention: Thermal Welding Technique (TWT)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Bipolar Cautery Dissection (BCD)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Classic Dissection (CD)
Number of subjects: 305

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 305
Study: 20368505

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 36

Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 36
Study: 18565733

Group type: EXPERIMENTAL
Intervention: Micro-Expression Training Tool (METT; n=26)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Repeated Exposure (RE; n=14)
Number of subjects: 40
Study: 16354341

Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency volumetric tissue reduction of the palate (BRVTR)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Laser-assisted uvulopalatoplasty (LAUP)
Number of subjects: 150
Study: 12735429

Group type: EXPERIMENTAL
Intervention: Bruxism self-aware group (14 subjects)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bruxism unaware group (16 subjects)
Number of subjects: 30
Study: 10449550

Group type: EXPERIMENTAL
Intervention: Low dose bromocriptine
Number of subjects: 149

Group type: COMPARATOR
Intervention: Low dose levodopa‐carbidopa
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Overall patients
Number of subjects: 149
Study: 9196546

Group type: EXPERIMENTAL
Intervention: Pyridostigmine bromide (30 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 1753613

Group type: EXPERIMENTAL
Intervention: Finoptin
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 6340404

Group type: EXPERIMENTAL
Intervention: Continuous transcutaneous PO2 measurements supplemented by blood-gas measurements only when judged necessary
Number of subjects: 20

Group type: COMPARATOR
Intervention: Repeated blood-gas determinations according to the usual practice
Number of subjects: 20
Study: 30923094

Group type: EXPERIMENTAL
Intervention: Bortezomib-dexamethasone induction treatment followed by high-dose melphalan and autologous stem cell transplantation (SCT)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Bortezomib-dexamethasone induction treatment
Number of subjects: 50
Study: 29978932

Group type: EXPERIMENTAL
Intervention: High rate cut-off VT zone ≥200 bpm (Arm B)
Number of subjects: 1391

Group type: EXPERIMENTAL
Intervention: 60 seconds delay in VT zone 170-199 bpm (Arm C)
Number of subjects: 1391

Group type: EXPERIMENTAL
Intervention: Delayed VT therapy (Arm C)
Number of subjects: 1391
Study: 27769284

Group type: EXPERIMENTAL
Intervention: Berberine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 25151520

Group type: EXPERIMENTAL
Intervention: Group attention during exposure to scary advertisements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group attention during exposure to negative images
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group attention during exposure to positive images
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group attention during a video depicting homelessness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group attention during sad videos
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group attention during amusing videos
Number of subjects: 0
Study: 21667200

Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 149
Study: 19114229

Group type: EXPERIMENTAL
Intervention: Haishengsu (2.4mg in 250ml normal saline, iv, for 15 days)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo (250ml normal saline, iv)
Number of subjects: 83
Study: 17173959

Group type: EXPERIMENTAL
Intervention: Colposcopy plus Optical Detection System (ODS)
Number of subjects: 2186

Group type: COMPARATOR
Intervention: Colposcopy only
Number of subjects: 2186
Study: 17185116

Group type: COMPARATOR
Intervention: Active control noninferiority trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 14739855

Group type: EXPERIMENTAL
Intervention: Insulin treatment (n=9) at a continuous rate of >=1.5 microU/kg/min to maintain euglycemia (serum glucose 100‐140 microg/dL)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Insulin treatment (n=9)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No treatment (control group, n=9)
Number of subjects: 18
Study: 11165310

Group type: EXPERIMENTAL
Intervention: Zolpidem (10 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Temazepam (30 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 9069080

Group type: EXPERIMENTAL
Intervention: Low-energy laser application
Number of subjects: 18

Group type: COMPARATOR
Intervention: Denture removal
Number of subjects: 18

Group type: COMPARATOR
Intervention: Relined dentures with temporary tissue treatment
Number of subjects: 18
Study: 8370425

Group type: EXPERIMENTAL
Intervention: MOCCA (methylprednisolone, vincristine, lomustine, cyclophosphamide, melphalan)
Number of subjects: 138

Group type: COMPARATOR
Intervention: COLA (vincristine, lomustine, cyclophosphamide, melphalan)
Number of subjects: 138
Study: 3539162

Group type: EXPERIMENTAL
Intervention: Thrombolysis
Number of subjects: 533

Group type: COMPARATOR
Intervention: Control
Number of subjects: 533
Study: 30361956

Group type: EXPERIMENTAL
Intervention: Retroperitoneal laparoscopic pyelolithotomy (RLP)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Percutaneous nephrolithotomy (PCNL)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Both RLP and PCNL
Number of subjects: 105
Study: 27634921

Group type: EXPERIMENTAL
Intervention: High-intensity stepping training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional lower-intensity interventions
Number of subjects: 0
Study: 25873729

Group type: COMPARATOR
Intervention: Low-dose unfractionated heparin (50 U/kg)
Number of subjects: 2026

Group type: COMPARATOR
Intervention: Standard-dose unfractionated heparin (85 U/kg or 60 U/kg with glycoprotein IIb/IIIa inhibitors, with ACT guidance)
Number of subjects: 2026

Group type: EXPERIMENTAL
Intervention: ACT≤300 s (in patients not receiving planned glycoprotein IIb/IIIa inhibitors)
Number of subjects: 2026

Group type: EXPERIMENTAL
Intervention: ACT
Number of subjects: 2026
Study: 23703418

Group type: EXPERIMENTAL
Intervention: Ultrasonography to determine the relative relationship of the ulnar artery and median nerve to the PL tendon
Number of subjects: 30

Group type: COMPARATOR
Intervention: Blind local steroid injection
Number of subjects: 30
Study: 21242389

Group type: EXPERIMENTAL
Intervention: Photographic sun damage assessment scale graded by dermatologists
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Blinded rating by 5 community dermatologists using the dermatologic assessment scoring scale
Number of subjects: 96
Study: 19482767

Group type: EXPERIMENTAL
Intervention: Nebulized 2% lidocaine at 4 mg/kg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 36
Study: 16956331

Group type: EXPERIMENTAL
Intervention: Laparoscopic Burch colposuspension (LBC)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Open Burch colposuspension (OBC)
Number of subjects: 200
Study: 15365964

Group type: EXPERIMENTAL
Intervention: 3 mg/kg/dialysis iron-sucrose for Group A (iron deficient)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg/dialysis iron-sucrose for Group B (iron-replete)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 1 mg/kg/dialysis iron-sucrose for Group A (after initial treatment)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg/dialysis iron-sucrose for Group B (maintenance)
Number of subjects: 14

Group type: COMPARATOR
Intervention: No treatment for Group C (possible iron-overloaded)
Number of subjects: 14
Study: 11352248

Group type: EXPERIMENTAL
Intervention: Etanercept (25 mg subcutaneously twice weekly) added to standard therapies for WG
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Etanercept (25 mg subcutaneously twice weekly)
Number of subjects: 20
Study: 9869995

Group type: EXPERIMENTAL
Intervention: 90 uF three-electrode defibrillation system
Number of subjects: 26

Group type: COMPARATOR
Intervention: 125 uF two-electrode defibrillation system
Number of subjects: 26
Study: 11271220

Group type: EXPERIMENTAL
Intervention: Sandimmun Neoral
Number of subjects: 552

Group type: COMPARATOR
Intervention: Sandimmun
Number of subjects: 552
Study: 2498954

Group type: EXPERIMENTAL
Intervention: Ethanol (0.1 g/kg per dose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30676406

Group type: EXPERIMENTAL
Intervention: Intraoperative fluoroscopy
Number of subjects: 133
Study: 28052266

Group type: EXPERIMENTAL
Intervention: mfERG normative database
Number of subjects: 78
Study: 25596138

Group type: EXPERIMENTAL
Intervention: BUD/FM BAI 2 × 160/4.5 μg bid
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: BUD/FM pMDI 2 × 160/4.5 μg bid
Number of subjects: 214

Group type: COMPARATOR
Intervention: BUD pMDI 2 × 160 μg bid
Number of subjects: 214
Study: 24107857

Group type: EXPERIMENTAL
Intervention: School-based active play intervention (6-week active play programme)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison group (usual practice)
Number of subjects: 0
Study: 21726291

Group type: EXPERIMENTAL
Intervention: Antacid tablet
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Gum arabic lozenge
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Mineral water
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Milk
Number of subjects: 11

Group type: COMPARATOR
Intervention: Tap water
Number of subjects: 11

Group type: COMPARATOR
Intervention: No product use
Number of subjects: 11
Study: 19110988

Group type: EXPERIMENTAL
Intervention: Upper endoscopy with biopsies
Number of subjects: 52
Study: 16330117

Group type: EXPERIMENTAL
Intervention: 25 mg of rofecoxib (n=21)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo (n=22)
Number of subjects: 43
Study: 15053241

Group type: EXPERIMENTAL
Intervention: Serum IL-6 in stroke patients
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Cortisol levels in stroke patients
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Diurnal variations of cortisol
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Serum IL-6 levels in stroke patients
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Correlation of IL-6 and cortisol in stroke patients
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Morning serum IL-6 level
Number of subjects: 39
Study: 11424113

Group type: EXPERIMENTAL
Intervention: Oseltamivir for 5 days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo for 5 days
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups (oseltamivir and placebo)
Number of subjects: 16
Study: 9262212

Group type: EXPERIMENTAL
Intervention: Gradual visual feedback rotation (10 degree-step increments up to 90 degrees)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Constant visual feedback rotation (90 degrees throughout the experiment)
Number of subjects: 0
Study: 8316982

Group type: EXPERIMENTAL
Intervention: External hip protectors
Number of subjects: 447

Group type: COMPARATOR
Intervention: No external hip protectors (control)
Number of subjects: 447
Study: 3551507

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg (two 10 mg capsules, t.i.d.)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg
Number of subjects: 28
Study: 29728364

Group type: EXPERIMENTAL
Intervention: Gestational diabetes mellitus (GDM) without subsequent diabetes
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Gestational diabetes mellitus (GDM) with subsequent diabetes
Number of subjects: 1226

Group type: COMPARATOR
Intervention: Women without GDM or subsequent diabetes (Control group)
Number of subjects: 1226
Study: 28073840

Group type: EXPERIMENTAL
Intervention: Sonidegib 200 mg daily
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Sonidegib 800 mg daily
Number of subjects: 230
Study: 25963351

Group type: EXPERIMENTAL
Intervention: Hyperventilation under isoflurane anesthesia
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hyperventilation under propofol anesthesia
Number of subjects: 20

Group type: COMPARATOR
Intervention: Moderate hyperventilation under propofol anesthesia
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normoventilation under propofol anesthesia
Number of subjects: 20
Study: 22544839

Group type: EXPERIMENTAL
Intervention: Anxiety Sensitivity (AS)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Panic attack history
Number of subjects: 242
Study: 21666941

Group type: EXPERIMENTAL
Intervention: midazolam + fentanyl sedation (Group S)
Number of subjects: 30

Group type: COMPARATOR
Intervention: general anesthesia (Group G)
Number of subjects: 30
Study: 18288935

Group type: EXPERIMENTAL
Intervention: Rofecoxib
Number of subjects: 189

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189
Study: 16772796

Group type: EXPERIMENTAL
Intervention: Bisphosphonate-type compounds (calcitonin, clodronate, alendronate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous phentolamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Steroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thalidomide and TNF-alpha blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gabapentin, tricyclic antidepressants, opioids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intensive physical therapy, nerve blocks, sympathectomy, intraspinally administered drugs, neuromodulatory therapies (spinal cord stimulation)
Number of subjects: 0
Study: 12789896

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11140235

Group type: EXPERIMENTAL
Intervention: Dexamphetamine
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 9160820

Group type: EXPERIMENTAL
Intervention: Vegetable diet (25% +/- 3% fat calories)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control diet (29% +/- 2% fat calories)
Number of subjects: 10
Study: 7525652

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HDMTX) 1 g/m2 per 24 h i.v., n = 47
Number of subjects: 101

Group type: COMPARATOR
Intervention: Low-dose methotrexate (LDMTX) 30 mg/m2 by mouth every 6 h x 6, n = 54
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Both treatments (HDMTX and LDMTX)
Number of subjects: 101
Study: 3597106

Group type: EXPERIMENTAL
Intervention: Intervention agencies
Number of subjects: 100

Group type: COMPARATOR
Intervention: Comparison agencies
Number of subjects: 100
Study: 29843781

Group type: EXPERIMENTAL
Intervention: Daptomycin
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 27863314

Group type: EXPERIMENTAL
Intervention: Cognitive remediation (CR)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Computer skills control intervention
Number of subjects: 112
Study: 26333801

Group type: EXPERIMENTAL
Intervention: Mindfulness-based therapy (MT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Social support (SS)
Number of subjects: 60
Study: 24520757

Group type: EXPERIMENTAL
Intervention: Ultrasound of calcaneus
Number of subjects: 100

Group type: COMPARATOR
Intervention: DXA (dual-energy X-ray absorptiometry)
Number of subjects: 100
Study: 21632497

Group type: EXPERIMENTAL
Intervention: Intensive BP control (systolic BP ≤ 130 mm Hg)
Number of subjects: 37736

Group type: COMPARATOR
Intervention: Standard BP control (systolic BP ≤ 140 mm Hg)
Number of subjects: 37736

Group type: EXPERIMENTAL
Intervention: More intensive BP control (systolic BP < 130 mm Hg)
Number of subjects: 37736

Group type: EXPERIMENTAL
Intervention: Systolic BP < 130 mm Hg
Number of subjects: 37736
Study: 18326958

Group type: EXPERIMENTAL
Intervention: Amlodipine/valsartan 5/160 mg
Number of subjects: 894

Group type: EXPERIMENTAL
Intervention: Amlodipine/valsartan 10/160 mg
Number of subjects: 894
Study: 16996004

Group type: EXPERIMENTAL
Intervention: PRP and BPBM (test group, n = 9)
Number of subjects: 10

Group type: COMPARATOR
Intervention: BPBM alone (control group, n = 8)
Number of subjects: 10
Study: 12687824

Group type: EXPERIMENTAL
Intervention: DDD+ mode
Number of subjects: 100

Group type: COMPARATOR
Intervention: DDD mode
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Overdrive pacing
Number of subjects: 100
Study: 12557136

Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg daily)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 257
Study: 10682150

Group type: EXPERIMENTAL
Intervention: 10 mg zanamivir powder for inhalation
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 10 mg zanamivir powder for inhalation plus 6.4 mg zanamivir nasal spray
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 8922541

Group type: EXPERIMENTAL
Intervention: Impaired glucose tolerance (IGT)
Number of subjects: 183

Group type: COMPARATOR
Intervention: BMI of 30 kg/m2 or more
Number of subjects: 183

Group type: COMPARATOR
Intervention: Increase in BMI during follow-up
Number of subjects: 183

Group type: COMPARATOR
Intervention: Fasting insulin levels of 8.1-12.9 mU/1
Number of subjects: 183

Group type: COMPARATOR
Intervention: Fasting insulin levels of 13.0 mU/1 or more
Number of subjects: 183

Group type: COMPARATOR
Intervention: Degree of glucose intolerance and diagnosis of hypertension
Number of subjects: 183
Study: 1991783

Group type: EXPERIMENTAL
Intervention: Closed intramedullary nailing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 0
Study: 6340158

Group type: EXPERIMENTAL
Intervention: Hexabrix (meglumine iothalamate)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conray (meglumine ioxaglate)
Number of subjects: 30
Study: 2948752

Group type: EXPERIMENTAL
Intervention: High-sodium diet (300 mmol per day)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Low-sodium diet (40 mmol per day)
Number of subjects: 6
Study: 31994262

Group type: EXPERIMENTAL
Intervention: Designed program based on game situations (Experimental Group - EG)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Adapted Physical Education (APE) program (Control Group - CG)
Number of subjects: 28
Study: 29332135

Group type: EXPERIMENTAL
Intervention: Sequential GnRHa treatment
Number of subjects: 216

Group type: COMPARATOR
Intervention: Simultaneous GnRHa treatment
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 216
Study: 27521254

Group type: EXPERIMENTAL
Intervention: Protein intake ≥60 g/d
Number of subjects: 77